Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
43
datasets available to search
ShareScore release 0.9.0
Dataset results
43 results for “Allogenic T-cells”
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
ClinicalTrials.gov study NCT01131169. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
ClinicalTrials.gov study NCT00943319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00506129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refrac
ClinicalTrials.gov study NCT06986382. IPD Sharing: NO. Countries: 1. Publications: 13.
Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
ClinicalTrials.gov study NCT02431988. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis
ClinicalTrials.gov study NCT02520908. IPD Sharing: Not stated. Countries: 1. Publications: 2.
T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov study NCT00306332. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT02227641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
ClinicalTrials.gov study NCT03692429. IPD Sharing: NO. Countries: 2. Publications: 1.
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
ClinicalTrials.gov study NCT03663933. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplan
ClinicalTrials.gov study NCT00582933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells
ClinicalTrials.gov study NCT01050764. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02136797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01646645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00683046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02350777. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
ClinicalTrials.gov study NCT00505921. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic T
ClinicalTrials.gov study NCT01621477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03883906. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
GEO Series GSE222633. Homo sapiens. 52 samples. Type: Expression profiling by high throughput sequencing; Other.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.